Model Aims to Give Insight into Heart Disease Mechanisms

By Salvatore Salamone

Jan. 23, 2008 | To get a better understanding how the mechanisms of certain diseases work in order to develop better drugs and better treatments, researchers at the Université de Montréal (UdM) have run a two billion element model of the heart, which they claim is the largest mathematical simulation of a heart ever assembled.

The model seeks to discover the electrical triggers and mechanisms of the various kinds of heart disease. Once the disease mechanisms are fully understood, researchers will then be able to devise the best drug or cure — surgical or otherwise.

Over the last year, Dr. Mark Potse and Dr Alain Vinet, both affiliated with the Research Center of Sacré-Cœur Hospital and the Biomedical Engineering department at UdM, began running 100 to 120 million point models on an SGI Altix 4700 system, which is shared by many researchers across Canada. In those simulations, they used 60 of the 768 Intel Itanium 2 processors within the system.

More recently, the pair had the chance to use the entire SGI Altix system and its 1.2 TB of shared memory. This allowed them to run their two billion element custom electrocardiography (ECG) code to simulate the largest, most detailed heart model ever.

The run simulated 5 milliseconds of activation in a tissue block that included some properties of a real heart. The run took two hours, which Potse says is a short time for this type of simulation. A full heartbeat would take two weeks of compute time on the system, and researchers cannot do this since the system is shared.

However, the test gave Poste and Vinet insight into ways to improve the model. “This was a test to see if the simulation works and to determine that, if we have a much bigger machine, [would] our software be able to run more efficiently,” said Potse. “This capability is really for the future when we can use this size of machine on a regular basis.”

------------------------
This article first appeared in Bio-IT World’s Inside IT newsletter. Click here for a free subscription to Inside IT.

White Papers & Special Reports

Waters white paper image
Software Helps Doping Control Lab Streamline Results Management
Sponsored by Waters
The Karolinska University Hospital’s Doping Control Lab tests thousands of samples annually for stimulants, diuretics, and other masking agents. Increased regulatory pressure and new technologies increased the number of samples analyzed creating data management challenges. Waters® NuGenesis® Scientific Data Management System and TargetLynx™ Application Manager software were used to reduce the time required to calculate, review and search results.


sas whitepaper92
Managed Innovation, Assured Compliance
Sponsored by SAS
Discovery organizations are identifying a lot of promising compounds, but clinical research processes haven't kept pace with timely testing of all those potential therapies. This white paper describes how SAS® Drug Development supports true innovation across the clinical trial process.

In this white paper you will learn how to:

  • Assemble data to foster better collaboration
  • Get up-to-date information during clinical trials
  • Make informed decisions earlier in the trial process


BlueArc white paper image
Addressing Life Sciences Constantly Growing Data Challenges Research Environments
Sponsored by BlueArc
The continued explosion of raw experimental data, the increased use of video, the growing adoption of new data retention practices, and the move to high throughput computational workflows are all placing new demands on the way life sciences organizations store and manage their data.

Download this white paper to learn about:

  • Factors driving the data explosion in the life sciences
  • New data management issues that must be addressed
  • HPC trends that are placing new demands on storage
  • Storage solution attributes that address performance, manageability, and energy efficiency.


Life Science Webcasts & Podcasts

Medidata Solutions

Rising Clinical Trial Delays and Costs - Addressing the Cause, Not the Symptoms 

medidata podcastProtocol complexity is taking a toll on clinical study speed and efficiency: increasingly complicated and ambitious protocols are not only burdening sites and study volunteers but are also prolonging trials and increasing expenses. In response, sponsors have turned to global study placement, restructured site relationships and new site management practices, but the problem remains.

This podcast will discuss:

  • Why these responses address only the symptoms, not the underlying cause, of rising clinical trial delays and costs.
  • Results of a recent joint Tufts University / Medidata Solutions study.
  • New metrics benchmarking protocol design trends.
  • Systematic protocol design improvements and why they are essential to clinical trial performance excellence.

Speakers: Ken Getz, Senior Research Fellow at the Tufts Center for the Study of Drug Development, and Ed Seguine, General Manager, Trial Planning Solutions at Medidata.

Download Now 



More Podcasts

Job Openings

Director, Center For Information Technology (CIT) - National Institutes of Health  (NIH), Department of Health and Human Service
Located in Bethesda, MD. This position requires:
• High-level vision, leadership, management, and modernization of CIT programs and services.
• Strategic direction and policy development for CIT long-term operations and objectives.
• Serve as a key IT advisor to the NIH Chief Information Officer.
A TOP SECRET security clearance will be required.  More job detail is found at:  http://www.jobs.nih.gov under the Executive Jobs section.Or contact Ms.Winnie Garner at seniorre@od.nih.gov.  Applications must be received ELECTRONICALLY by (11:59 p.m.), December 17, 2008.  DHHS and NIH are Equal Opportunity Employers

Bioinformatics Manager- Lilly Singapore Centre for Drug Discovery
For more information click here 

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.